Navigating Independence: Insights into Consulting, Small Business, and Drug Development with Jeff Fielhauer
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on March 12, 2024 15:27 ()
What now? This series will be checked again in the next hour. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 406076441 series 3556911
Drug sponsors face challenges with independent consultants. Jeff Fielhauer of Greenforce Medical Writing discusses the corporate ladder's limitations and the perks of small businesses, covering incorporation, tax considerations, & 1099 vs. W2 economics. He refutes the notion that consultants are pricier than full-time employees. Topics include various contracts, working with small vs. large pharma, and AI's impact on drug development, and more!
2 jakso